Arkolith/Insider Trading/BCTX/Form 4

Lustig Marc

Director, 10% OwnerBriaCell Therapeutics Corp. (BCTX) · full profile →Form 4 · filed May 20, 2024
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2024Buy(P)903K$2.22$2.0M2.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 14, 2024Buy(P)903K——903K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-020660) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML